High expression of microRNA 221 is a poor predictor for glioma

Yanlin Song1,2, Min He3, Jing Zhang1

  • 1Department of Neurosurgery and National Clinical Research Center for Geriatrics.

Medicine
|December 8, 2020
PubMed
Abstract

Insights

High microRNA 221 expression indicates a poor prognosis for glioma patients. This meta-analysis confirms its role in predicting overall survival and disease-free survival, aiding future glioma research.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biomarker Research

Background:

  • MicroRNA 221 (miR-221) is implicated as a potential biomarker in various cancers.
  • Previous studies on miR-221's role in glioma prognosis have yielded conflicting results.
  • A systematic evaluation is needed to clarify the prognostic significance of miR-221 in glioma.

Purpose of the Study:

  • To conduct a meta-analysis systematically evaluating the prognostic role of microRNA 221 in glioma.
  • To synthesize existing evidence regarding the association between miR-221 expression and patient outcomes in glioma.

Main Methods:

  • Comprehensive literature search across major databases (PubMed, Web of Science, EMBASE, Cochrane Library, CNKI).
  • Extraction of relevant data and characteristics from eligible studies.
  • Pooled analysis of Hazard Ratios (HRs) with 95% Confidence Intervals (CIs) to assess prognostic value.

Main Results:

  • Eight studies comprising 1069 glioma patients were included in the meta-analysis.
  • Elevated miR-221 expression was significantly associated with poorer overall survival (HR = 1.66, 95% CI: 1.34-2.04).
  • Increased miR-221 levels also correlated with reduced disease-free survival (HR = 1.14, 95% CI: 1.02-1.26).

Conclusions:

  • High expression of microRNA 221 is linked to unfavorable prognosis in glioma patients.
  • These findings support miR-221 as a potential predictive biomarker for glioma.
  • Further research is recommended to address the heterogeneity observed across studies and solidify clinical application.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.3K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.5K